ANNEXON, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period
ANNEXON, INC. (ANNX) reported Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period of 751.35 thousand shares for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-12.
Financial Statements › Shareholders' Equity › Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Grants in Period, Net of Forfeitures
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod · last filed 2026-08-12
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-06-30 was 451.38K shares, a 15.91% decline year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2026-03-31 was 299.97K shares, a 94.56% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-12-31 was 732.26K shares, a 957.44% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for the quarter ending 2025-09-30 was 697.14K shares, a 273.85% increase year-over-year.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2025 was 2.12M shares, a 115.93% increase from fiscal 2024.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2024 was 981.95K shares, a 33.12% decline from fiscal 2023.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2023 was 1.47M shares, a 16.24% increase from fiscal 2022.
- ANNEXON, INC. share-based compensation arrangement by share-based payment award, options, forfeitures in period for fiscal 2022 was 1.26M shares, a 73.73% increase from fiscal 2021.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period 12 month |
|---|---|---|---|---|
| 2026-06-30 | 451.38K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-12 | 751.35K shares 10-Q · filed 2026-08-12 | 1.48M shares derived: sum of 3 quarters · filed 2026-08-12 | 2.18M shares derived: sum of 4 quarters · filed 2026-08-12 |
| 2026-03-31 | 299.97K shares 10-Q · filed 2026-05-07 | 1.03M shares derived: sum of 2 quarters · filed 2026-05-07 | 1.73M shares derived: sum of 3 quarters · filed 2026-05-07 | 2.27M shares derived: sum of 4 quarters · filed 2026-05-07 |
| 2025-12-31 | 732.26K shares derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-30 | 1.43M shares derived: sum of 2 quarters · filed 2026-03-30 | 1.97M shares derived: sum of 3 quarters · filed 2026-03-30 | 2.12M shares 10-K · filed 2026-03-30 |
| 2025-09-30 | 697.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-10 | 1.23M shares derived: sum of 2 quarters · filed 2025-11-10 | 1.39M shares 10-Q · filed 2025-11-10 | 1.46M shares derived: sum of 4 quarters · filed 2025-11-10 |
| 2025-06-30 | 536.76K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | 690.94K shares 10-Q · filed 2025-08-14 | 760.19K shares derived: sum of 3 quarters · filed 2025-08-14 | 946.66K shares derived: sum of 4 quarters · filed 2025-08-14 |
| 2025-03-31 | 154.18K shares 10-Q · filed 2025-05-12 | 223.43K shares derived: sum of 2 quarters · filed 2025-05-12 | 409.90K shares derived: sum of 3 quarters · filed 2025-05-12 | 770.46K shares derived: sum of 4 quarters · filed 2025-05-12 |
| 2024-12-31 | 69.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-03 | 255.72K shares derived: sum of 2 quarters · filed 2025-03-03 | 616.28K shares derived: sum of 3 quarters · filed 2025-03-03 | 981.95K shares 10-K · filed 2025-03-03 |
| 2024-09-30 | 186.47K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-14 | 547.03K shares derived: sum of 2 quarters · filed 2024-11-14 | 912.70K shares 10-Q · filed 2024-11-14 | 1.20M shares derived: sum of 4 quarters · filed 2024-11-14 |
| 2024-06-30 | 360.56K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-12 | 726.23K shares 10-Q · filed 2024-08-12 | 1.02M shares derived: sum of 3 quarters · filed 2024-08-12 | 1.27M shares derived: sum of 4 quarters · filed 2024-08-12 |
| 2024-03-31 | 365.67K shares 10-Q · filed 2024-05-13 | 654.51K shares derived: sum of 2 quarters · filed 2024-05-13 | 911.40K shares derived: sum of 3 quarters · filed 2024-05-13 | 1.38M shares derived: sum of 4 quarters · filed 2024-05-13 |
| 2023-12-31 | 288.83K shares derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-26 | 545.72K shares derived: sum of 2 quarters · filed 2024-03-26 | 1.01M shares derived: sum of 3 quarters · filed 2024-03-26 | 1.47M shares 10-K · filed 2024-03-26 |
| 2023-09-30 | 256.89K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | 721.62K shares derived: sum of 2 quarters · filed 2023-11-13 | 1.18M shares 10-Q · filed 2023-11-13 | 1.32M shares derived: sum of 4 quarters · filed 2023-11-13 |
| 2023-06-30 | 464.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-07 | 922.56K shares 10-Q · filed 2023-08-07 | 1.07M shares derived: sum of 3 quarters · filed 2023-08-07 | 1.11M shares derived: sum of 4 quarters · filed 2023-08-07 |
| 2023-03-31 | 457.83K shares 10-Q · filed 2023-05-08 | 602.38K shares derived: sum of 2 quarters · filed 2023-05-08 | 641.04K shares derived: sum of 3 quarters · filed 2023-05-08 | 998.79K shares derived: sum of 4 quarters · filed 2023-05-08 |
| 2022-12-31 | 144.55K shares derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-06 | 183.21K shares derived: sum of 2 quarters · filed 2023-03-06 | 540.96K shares derived: sum of 3 quarters · filed 2023-03-06 | 1.26M shares 10-K · filed 2023-03-06 |
| 2022-09-30 | 38.66K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03 | 396.40K shares derived: sum of 2 quarters · filed 2022-11-03 | 1.12M shares 10-Q · filed 2022-11-03 | 1.37M shares derived: sum of 4 quarters · filed 2022-11-03 |
| 2022-06-30 | 357.75K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-08 | 1.08M shares 10-Q · filed 2022-08-08 | 1.33M shares derived: sum of 3 quarters · filed 2022-08-08 | 1.61M shares derived: sum of 4 quarters · filed 2022-08-08 |
| 2022-03-31 | 722.24K shares 10-Q · filed 2022-05-09 | 975.57K shares derived: sum of 2 quarters · filed 2022-05-09 | 1.25M shares derived: sum of 3 quarters · filed 2022-05-09 | 1.38M shares derived: sum of 4 quarters · filed 2022-05-09 |
| 2021-12-31 | 253.33K shares derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | 525.38K shares derived: sum of 2 quarters · filed 2022-03-01 | 652.77K shares derived: sum of 3 quarters · filed 2022-03-01 | 727.10K shares 10-K · filed 2022-03-01 |
| 2021-09-30 | 272.06K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | 399.44K shares derived: sum of 2 quarters · filed 2021-11-09 | 473.77K shares 10-Q · filed 2021-11-09 | 473.77K shares derived: sum of 4 quarters · filed 2021-11-09 |
| 2021-06-30 | 127.39K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-16 | 201.72K shares 10-Q · filed 2021-08-16 | 201.72K shares derived: sum of 3 quarters · filed 2021-08-16 | 201.72K shares derived: sum of 4 quarters · filed 2021-08-16 |
| 2021-03-31 | 74.33K shares 10-Q · filed 2021-05-17 | 74.33K shares derived: sum of 2 quarters · filed 2021-05-17 | 74.33K shares derived: sum of 3 quarters · filed 2021-05-17 | |
| 2020-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-25 | 0.00 shares derived: sum of 2 quarters · filed 2021-03-25 | 2.64K shares 10-K · filed 2021-03-25 | |
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-16 | 2.64K shares 10-Q · filed 2020-11-16 | ||
| 2020-06-30 | 2.64K shares 10-Q · filed 2020-09-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Corbus Pharmaceuticals Holdings, Inc. (CRBP) | United States | $0.144B | -1.72 |
| SPRUCE BIOSCIENCES, INC. (SPRB) | United States | $0.142B | -2.89 |
| Korro Bio, Inc. (KRRO) | United States | $0.141B | -1.81 |
| Atrium Therapeutics, Inc. (RNA) | United States | $0.140B | |
| Curanex Pharmaceuticals Inc (CURX) | United States | $0.138B | |
| TuHURA Biosciences, Inc./NV (HURA) | United States | $0.134B | -4.88 |
| Unicycive Therapeutics, Inc. (UNCY) | United States | $0.134B | -3.70 |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| LIFECORE BIOMEDICAL, INC. DE (LFCR) | United States | $0.163B | -8.50 |